Loading clinical trials...
Loading clinical trials...
Multi-center, Double-blind, Randomized, Placebo-controlled, Parallel-group, Polysomnography Study to Assess the Efficacy and Safety of ACT-541468 in Adult and Elderly Subjects With Insomnia Disorder
Conditions
Interventions
Daridorexant
Placebo
Locations
86
United States
Pulmonary Associates, Pa
Glendale, Arizona, United States
Noble Clinical Research
Tucson, Arizona, United States
Baptist Health Center for Clinical Research
Little Rock, Arkansas, United States
Woodland International Research Group
Little Rock, Arkansas, United States
Core Healthcare Group
Cerritos, California, United States
Artemis Institute For Clinical Research - Riverside
Riverside, California, United States
Start Date
May 29, 2018
Primary Completion Date
April 9, 2020
Completion Date
May 14, 2020
Last Updated
March 25, 2022
NCT05780177
NCT06779149
NCT06767137
NCT06626048
NCT07542756
NCT07028697
Lead Sponsor
Idorsia Pharmaceuticals Ltd.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions